Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Evnin Luke
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   330,044    

Indirect Shares

   35,767,143      
Direct Value   $449,921    

Indirect Value

   $126,433,068      
Total Shares   36,097,187      
Total Value   $126,882,990      


iPass Inc $0 Tcr2 Therapeutics Inc. $449,921 iPass Inc $0 Tcr2 Therapeutics Inc. $449,921
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Oscient Pharmaceuticals Corp OSCIQ Director 0 2006-01-05 2,272,935    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2004-07-02 0 2004-07-02 1,833,597    Premium*  
            iPass Inc IPAS 10% Owner 2004-02-09 26,043 2004-02-09 262,533    Premium*  
            Hemosense Inc HEM 10% Owner 2005-07-01 0 2007-11-06 0    Premium*  
            American Cryostem Corporation CRYO 10% Owner 2005-07-13 0 2005-07-19 2,931,531    Premium*  
            Radius Health Inc. RDUS Former 10% stockholder 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Director 2013-06-13 0 2013-06-13 824,255    Premium*  
            Syndax Pharmaceuticals Inc SNDX Director, 10% Owner 2016-03-08 0 2016-03-08 2,168,691    Premium*  
            Harpoon Therapeutics, Inc. HARP Former 10% Owner 2019-02-12 0 2021-04-15 3,220,844    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 3,003,772    Premium*  
            Oncorus, Inc. ONCR Director, 10% Owner 0 2020-10-06 2,492,843    Premium*  
            Turmeric Acquisition Corp. TMPM Chief Executive Officer 2020-10-20 0 2020-10-20 415,500    Premium*  
            Werewolf Therapeutics, Inc. HOWL Director, 10% Owner 0 2021-05-04 4,284,172    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-22 304,001 2023-05-22 3,370,977    Premium*  
* Premium Members only  

Records found :    107         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HARP Harpoon Therapeutics, Inc... Former 10% Owner   –       –      –    2021-04-14 4 AS $20.06 $34,714 I/I (1,671) 3,221,896 0 %
HARP Harpoon Therapeutics, Inc... Former 10% Owner   –       –      –    2021-04-13 4 AS $19.35 $37,806 I/I (1,943) 3,223,567 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-04-12 4 AS $20.72 $52,460 I/I (2,496) 3,225,510 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-04-09 4 AS $23.67 $243,801 I/I (10,300) 3,228,006 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-10 4 AS $20.00 $3,661,020 I/I (183,051) 3,238,306 0 %
PCRX Pacira Pharmaceuticals, I... Director   –       •       •   2011-11-21 4 B $6.50 $2,999,997 I/I 461,538 3,290,479 2.25 -
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-21 4 AS $2.30 $587,469 I/I (255,000) 3,308,235 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-09 4 AS $20.25 $190,350 I/I (9,400) 3,421,357 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-08 4 AS $20.04 $1,445,445 I/I (72,128) 3,430,757 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-05 4 AS $20.01 $203,542 I/I (10,172) 3,502,885 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-04 4 AS $20.37 $605,600 I/I (29,730) 3,513,057 0 %
HEM Hemosense Inc 10% Owner   –       –       •   2005-07-01 4 A $0.00 $0 I/I 3,537,359 3,537,359 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-03 4 AS $20.21 $847,244 I/I (41,922) 3,542,787 0 %
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-19 4 AS $2.36 $5,428 I/I (2,300) 3,563,235 -
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-16 4 AS $2.30 $395,600 I/I (172,000) 3,565,535 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-02 4 AS $20.13 $974,715 I/I (48,421) 3,584,709 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-01-27 4 AS $20.00 $14,136,500 I/I (706,825) 3,633,130 0 %
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-15 4 AS $2.32 $534,135 I/I (230,300) 3,737,535 -
HEM Hemosense Inc 10% Owner   –       –       •   2007-09-13 4 S $12.79 $2,235,692 I/I (174,800) 3,828,319 0 -
HARP Harpoon Therapeutics, Inc... Director   –       •       •   2019-02-12 4 A $0.00 $0 I/I 3,521,767 3,843,830 0 -
RDUS Radius Health Inc. Former 10% stockholder   –       –      –    2016-09-27 4 D $0.00 $0 I/I (1,943,751) 3,887,502 0 -
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-14 4 AS $2.30 $122,452 I/I (53,240) 3,967,835 -
HEM Hemosense Inc 10% Owner   –       –       •   2007-09-12 4 S $12.75 $3,834,093 I/I (300,600) 4,003,119 0 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-19 4 AS $2.41 $96,324 I/I (40,000) 4,021,075 -
OSCIQ Oscient Pharmaceuticals C... Director   –       •      –    2005-09-16 4 AS $2.41 $252,588 I/I (105,000) 4,061,075 -
  107  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us